WCI
검색
Login
Sign Up
Sitemap
About Us
Message from the President
Mission
History
Charter
Bylaws
Organization
Linkage with other organizations
Membership
Membership
Organization Members
Individual Members
Student Members
Honorary Members
ICI
ICI History
ICI Chronicles
ICI Documents
ICI Photos
Publications
Newsletters
Brochures
Annual Activity Reports
Minutes
Adivisory Report
Training /
Seminar
Training Courses
Materials
Communication
Announcements
Events
RI Related News
RI Related News
Awards
Awards
Winners
Funding
Kinds of WCI funding
Acknowledgements
Community
RI Related News
RI Related News
Home > RI Related News > RI Related News
RI Related News
LOGIN
게시글 목록
No
TItle
Name
Date
Hit
756
AtomVie Global Radiopharma Inc. Announces its Spinout and Series A Financing with Avego
WCI Secretariat
2022/09/08
185
755
Aktis Oncology Announces Actinium-225 Supply Agreements with Leading Isotope Producers
WCI Secretariat
2022/09/08
186
754
ITM Acquires a New Platform for the Development of Next-Generation Theranostics
WCI Secretariat
2022/09/08
197
753
POINT Biopharma to Publish Abstract at ESMO Congress 2022 Containing Efficacy & Safety Data from Lead-In Cohort of Phase 3 SPLASH Trial
WCI Secretariat
2022/09/08
174
752
NRG and Curium Sign Multi-Year Isotope Production Contract
WCI Secretariat
2022/09/08
195
751
Fusion Pharmaceuticals Announces Second Quarter 2022 Financial Results And Clinical Program Updates
WCI Secretariat
2022/09/08
189
750
Imaging trial with SAR-Bombesin in prostate cancer opens for recruitment in Australia
WCI Secretariat
2022/09/08
193
749
Clarity and Evergreen expand Targeted Copper Theranostics manufacturing
WCI Secretariat
2022/09/08
193
748
Dutch regulator receives licence application for PALLAS reactor
WCI Secretariat
2022/09/08
202
747
Radiopharm Enters into Strategic Collaboration with LANTHEUS and Assumes PD-L1 Licensing Agreement from NANOMAB
WCI Secretariat
2022/09/08
190
746
New CRP: Understanding the importance of convective rain events and tracing their impact on the catchment with isotopes (F31007)
WCI Secretariat
2022/09/08
198
745
Ablaze Pharma Aligned The Strategic Agreement With Wenjiang District Government of Chengdu to Build-up the Innovative R&D and Manufacturing Center for Targeted Radiopharmaceutical Therapies
WCI Secretariat
2022/09/08
193
744
SHINE moving from R&D into the commercial stage for cancer therapy product, exec says
WCI Secretariat
2022/09/08
212
743
SHINE Submits Drug Master File for n.c.a. Lu-177
WCI Secretariat
2022/09/08
209
742
Zero-Spin Silicon Project Completes Construction of Stage 3 Pilot Demonstration Facility
WCI Secretariat
2022/08/04
231
First
Prev
1
2
3
4
5
6
7
8
9
10
Next
End (51 Page)
Name
Title
Contents
비밀글입니다!
글작성시 입력했던 비밀번호를 입력해주세요.
비밀번호 입력